Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Giant Cell Arteritis Revealed by Vertebrobasilar Insufficiency

SÉBASTIEN RICHARD, RENÉ ANXIONNAT, CAMILLE DELAUNAY and XAVIER DUCROCQ
The Journal of Rheumatology February 2009, 36 (2) 457-458; DOI: https://doi.org/10.3899/jrheum.080922
SÉBASTIEN RICHARD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.richard{at}chu-nancy.fr
RENÉ ANXIONNAT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAMILLE DELAUNAY
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
XAVIER DUCROCQ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

To the Editor:

Giant cell arteritis (GCA) is a rare cause of stroke involving cervical vertebral arteries. We describe a patient with no clinical symptoms of GCA and several cardiovascular risk factors. GCA was considered because of multiple and concentric stenosis of the right cervical vertebral artery and occlusion of the left one.

A 76-year-old man was admitted with a 1-month history of progressive onset of right facial paresthesia, dysarthria, gait ataxia, vertigo, and left hemiparesis. He had a history of hypertension, hypercholesterolemia, smoking, and coronary disease, and was taking a daily dose of aspirin 75 mg. He did not complain of headache, and temporal artery palpation was normal. Brain magnetic resonance imaging (MRI) scan showed right pontine and left cerebellar infarctions. Cervical MR angiography revealed occlusion of the left vertebral artery and severe stenosis of the right. This was confirmed by cerebral angiography (Figure 1A, 1B). Ultrasonography (Figure 1C) showed a concentric aspect to the stenosis. Erythrocyte sedimentation rate (ESR) was 60 mm/hour.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

A. Right vertebral angiogram revealed multiple and concentric stenosis. B. Cerebral angiography revealed multiple stenosis of the right vertebral artery in the extradural portion, a normal diameter of the intradural portion and of the basilar artery, and occlusion of the left vertebral artery. C. Ultrasonography showed concentric stenosis of the right vertebral artery.

The diagnosis of GCA was considered because of the patient’s age, the aspect of the stenosis of the right vertebral artery, and the elevated ESR. The diagnosis was confirmed by temporal artery biopsy (TAB) showing inflammatory cell infiltrate, multinucleate giant cells, and intimal proliferation, with a complete luminal occlusion of the artery (Figure 2). Prednisone 70 mg/day (1 mg/kg) was started and the daily dose of aspirin was increased to 160 mg. One month later, he complained of worsening dysarthria and ataxia. MRI showed new right pontine and left thalamic infarctions with a bilateral vertebral occlusion. He was given high-dose intravenous (IV) methylprednisolone (360 mg/day), and aspirin was replaced with heparin for activated partial thromboplastin time > 2. His condition deteriorated, with ataxia and coma, and he died a few days later.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Temporal artery biopsy (HES obj*10) showed inflammatory cell infiltrate with intimal proliferation with a complete luminal occlusion. This image = 60% of original magnification.

GCA causes vasculitis characterized by granulomatous inflammation in the wall of medium-size and large arteries and preferentially affects extracranial branches of the carotid artery1. Occlusion of the posterior ciliary arteries leading to anterior ischemic optic neuropathy is the most frequent complication, but cerebral arteries can also be involved, leading to cerebral infarction. Nesher, et al2 reported cranial ischemic complications (including visual loss and stroke) in 25% of a group of patients with GCA, but Wiszniewska, et al3 found only 0.15% of stroke in a population of 4086 patients with GCA. Vertebral arteries are more likely affected than internal carotid arteries, especially in the extradural portion, where there is more elastic tissue4. Our patient’s cerebral angiography showed multiple stenosis of this portion of the right vertebral artery, but the intracranial portion and the basilar artery were of normal diameter without stenosis (Figure 1B). Involvement of intracranial arteries is rare4, and cerebral infarctions are the hemodynamic consequences of occlusion of cervical arteries.

The ultrasonographic axial plan can show a concentric halo and T2-weigted MRI a slightly hyperintense vessel wall due to inflammatory mural thickening of arteries5.

The prognosis of GCA of the vertebral arteries is poor: reports reveal that most patients die or become dependent6. Sutter, et al7 and Ahdab, et al8 described cases with good outcome. The patients received high-dose IV methylprednisolone (500 to 1000 mg/day) for 5 days. Addition of other immunosuppressive treatments like cyclophosphamide is discussed, but no guidelines are put forward. Nesher, et al2 and Lee, et al9 suggested that antiplatelet or anticoagulation therapy may reduce ischemic complications.

Our patient had no symptom of GCA, with no headache, but the characteristics of multiple and concentric stenosis of the right vertebral artery pointed toward the diagnosis. TAB not only confirmed the diagnosis but also revealed a complete luminal obstruction. Makkuni, et al10 suggested that the degree of intimal hyperplasia was associated with ischemic complications in GCA.

Even if clinical symptoms are not evident, GCA should be considered in patients over age 50 years with multiple and concentric stenosis of extradural vertebral arteries. Diagnosis may be difficult in the absence of headache and presence of atherosclerotic risk factors, but poor prognosis can be worsened by the delay of immunosuppressive treatment.

REFERENCES

  1. 1.↵
    1. Warrington KJ,
    2. Matteson EL
    . Management guidelines and outcome measures in giant cell arteritis. Clin Exp Rheumatol 2007;25:137–41.
    OpenUrlPubMed
  2. 2.↵
    1. Nesher G,
    2. Berkun Y,
    3. Mates M,
    4. Baras M,
    5. Rubinow A,
    6. Sonnenblick M
    . Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 2004;50:1332–7.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Wiszniewska M,
    2. Devuyst G,
    3. Bogousslavsky J
    . Giant cell arteritis as a cause of first-ever stroke. Cerebrovasc Dis 2007;24:226–30.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Salvarani C,
    2. Giannini C,
    3. Miller DV,
    4. Hunder G
    . Giant cell arteritis: involvement of intracranial arteries. Arthritis Rheum 2006;55:985–9.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Reinhard M,
    2. Schmidt D,
    3. Schumacher M,
    4. Hetzel A
    . Involvement of the vertebral arteries in giant cell arteritis mimicking vertebral dissection. J Neurol 2003;250:1006–9.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Ruegg S,
    2. Engelter S,
    3. Jeanneret C,
    4. et al
    . Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine 2003;82:1–12.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Sutter R,
    2. Renaud S,
    3. Bonati L,
    4. et al
    . Bilateral vertebral giant cell arteritis — favourable outcome in two cases. J Neurol 2008;255:133–4.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Ahdab R,
    2. Thabuy F,
    3. Menager de Froberville E,
    4. Brugieres P,
    5. Hosseini H
    . Reversible vertebral artery stenosis following corticotherapy in giant cell arteritis. Eur Neurol 2008;59:331.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Lee MS,
    2. Smith SD,
    3. Galor A,
    4. Hoffman GS
    . Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 2006;54:3306–9.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Makkuni D,
    2. Bharadwaj A,
    3. Wolfe K,
    4. Payne S,
    5. Hutchings A,
    6. Dasgupta B
    . Is intimal hyperplasia a marker of neuro-ophthalmic complications of giant cell arteritis? Rheumatology Oxford 2008;47:488–90.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 36, Issue 2
1 Feb 2009
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Giant Cell Arteritis Revealed by Vertebrobasilar Insufficiency
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Giant Cell Arteritis Revealed by Vertebrobasilar Insufficiency
SÉBASTIEN RICHARD, RENÉ ANXIONNAT, CAMILLE DELAUNAY, XAVIER DUCROCQ
The Journal of Rheumatology Feb 2009, 36 (2) 457-458; DOI: 10.3899/jrheum.080922

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Giant Cell Arteritis Revealed by Vertebrobasilar Insufficiency
SÉBASTIEN RICHARD, RENÉ ANXIONNAT, CAMILLE DELAUNAY, XAVIER DUCROCQ
The Journal of Rheumatology Feb 2009, 36 (2) 457-458; DOI: 10.3899/jrheum.080922
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PPI Use and Its Significant Association With an Increased Incidence of Intestinal Behçet Disease
  • Dr. Murakami et al reply
  • Dr. Gensler et al reply
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire